These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38095635)

  • 1. Preoperative Dynamic Contrast-Enhanced and Diffusion-Weighted Breast Magnetic Resonance Imaging Findings for Prediction of Lymphovascular Invasion of the Lesions in Node-Negative Invasive Breast Cancer.
    Coşkun Bilge A; Yaltırık Bilgin E; Bulut ZM; Esen Bostancı I; Bilgin E
    Can Assoc Radiol J; 2024 May; 75(2):386-396. PubMed ID: 38095635
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer.
    Mori N; Mugikura S; Takasawa C; Miyashita M; Shimauchi A; Ota H; Ishida T; kasajima A; Takase K; Kodama T; Takahashi S
    Eur Radiol; 2016 Feb; 26(2):331-9. PubMed ID: 26024846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative MRI features associated with lymphovascular invasion in node-negative invasive breast cancer: A propensity-matched analysis.
    Cheon H; Kim HJ; Lee SM; Cho SH; Shin KM; Kim GC; Park JY; Kim WH
    J Magn Reson Imaging; 2017 Oct; 46(4):1037-1044. PubMed ID: 28370761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer.
    Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
    J Magn Reson Imaging; 2017 Jun; 45(6):1771-1779. PubMed ID: 27859961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
    Choi EJ; Youk JH; Choi H; Song JS
    J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.
    Durando M; Gennaro L; Cho GY; Giri DD; Gnanasigamani MM; Patil S; Sutton EJ; Deasy JO; Morris EA; Thakur SB
    Eur J Radiol; 2016 Sep; 85(9):1651-8. PubMed ID: 27501902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Lymphovascular Invasion in Breast Cancer Using a Combined MRI Morphological Features, Radiomics, and Deep Learning Approach Based on Dynamic Contrast-Enhanced MRI.
    Yang X; Fan X; Lin S; Zhou Y; Liu H; Wang X; Zuo Z; Zeng Y
    J Magn Reson Imaging; 2024 Jun; 59(6):2238-2249. PubMed ID: 37855421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast MRI for prediction of lymphovascular invasion in breast cancer patients with clinically negative axillary lymph nodes.
    Igarashi T; Furube H; Ashida H; Ojiri H
    Eur J Radiol; 2018 Oct; 107():111-118. PubMed ID: 30292254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast enhanced-MRI and diffusion-weighted image as predictors of lymphovascular invasion in node-negative invasive breast cancer.
    Choi BB
    World J Surg Oncol; 2021 Mar; 19(1):76. PubMed ID: 33722246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
    Youk JH; Son EJ; Chung J; Kim JA; Kim EK
    Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of MRI-based deep learning model for lymphovascular invasion status in node-negative invasive breast cancer.
    Liang R; Li F; Yao J; Tong F; Hua M; Liu J; Shi C; Sui L; Lu H
    Sci Rep; 2024 Jul; 14(1):16204. PubMed ID: 39003325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer.
    Chen H; Meng X; Hao X; Li Q; Tian L; Qiu Y; Chen Y
    J Immunol Res; 2022; 2022():7150304. PubMed ID: 36249424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
    Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
    J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer.
    Ni-Jia-Ti MY; Ai-Hai-Ti DL; Huo-Jia AS; Wu-Mai-Er PL; A-Bu-Li-Zi AB; Shi Y; Rou-Zi NE; Su WJ; Dai GZ; Da-Mo-la MH
    BMC Cancer; 2020 Feb; 20(1):94. PubMed ID: 32013960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional value of diffusion-weighted imaging to evaluate multifocal and multicentric breast cancer detected using pre-operative breast MRI.
    Song SE; Park EK; Cho KR; Seo BK; Woo OH; Jung SP; Cho SB
    Eur Radiol; 2017 Nov; 27(11):4819-4827. PubMed ID: 28593433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
    Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
    Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.